RFA-HL-23-008 - NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
RESCINDED - NHLBI Notice of Clarification and Availability of Frequently Asked Questions (FAQs) for RFA-HL-23-008 and RFA-HL-23-009 "NHLBI SBIR Phase IIB Small Market Awards" NOT-HL-23-082 NHLBI Mar 16, 2023 n/a R44


Technical Issues: E-mail OER Webmaster